Proactive Investors Interview with CEO and Chair
CEO and Chairman interviews published on Proactive Investors platform.
Select text to share a quote on X · sign in to keep highlights & notes in your SVNS notes
Proactive Investors interviews with CEO and Chairman
Graft Polymer, an innovative biotechnology company co-developing therapeutics for mental health disorders, announces interviews on Proactive Investors with Anthony Tennyson, CEO and Dennis Purcell, Chairman. The interview with Anthony Tennyson can we viewed now at https://www.proactiveinvestors.co.uk/LON:GPL/Graft-Polymer-UK-PLC and the interview with Dennis Purcell will be available from this Thursday, 19 December 2024.
Graft Polymer (UK) Plc is an innovative biotechnology company focused on developing intellectual property relating to the treatment of mental health and substance use disorders, and the co-development of therapeutics for mental health disorders. Our mission is to improve outcomes for individuals suffering from these conditions, with an initial focus on trauma-related mental health disorders, such as PTSD, which affected approximately 13 million adults in the U.S. in 2020, with the Company estimating a current affected population of 20 million across the US, UK and key EU markets.
For more information, please visit www.graftpolymer.co.uk.
About Reach announcements
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.